Eli Lilly & Co said that the late-stage trial of its Verzenio treatment showed to reduce the risk of breast cancer recurrence by …
Eli Lilly has revealed that it has now received approval from the U.S.
Morgan Stanley upgraded Eli Lilly to Buy from Hold and raised the stock’s price target to $176 (17.7% upside potential) from $157, citing …
The pharmaceutical industry is considered to be more resilient in difficult economic times compared to other industries. However, this time around, the coronavirus-led …
Eli Lilly (LLY) and Innovent Biologics have announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug …
Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer …
Eli Lilly has announced the initiation of BLAZE-2, a Phase 3 trial studying LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in …
Shares of Eli Lilly & Co. (LLY) fell 5.
Hutchison China MediTech (HCM) and Eli Lilly (LLY) have announced an amendment to the 2013 License and Collaboration Agreement on Fruquintinib. The 2020 …
Shares in Eli Lilly & Co (LLY) jumped 13% after the drugmaker reported that the results of a late stage study of its …
